Literature DB >> 25549950

The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: a systematic review.

H C van Wyk1, James Park2, Campbell Roxburgh2, Paul Horgan2, Alan Foulis3, Donald C McMillan2.   

Abstract

Tumour budding reflects a detachment of tumour cells at the invasive front of carcinomas and is presumed to be an early step in the metastatic process. Tumour budding has received some attention in colorectal cancer as it has been proposed as an additional prognostic factor in colorectal cancer that may stratify patients into risk categories. The purpose of the review was to examine (1): The different methods of detection using either routine stains (H&E) or immunohistochemistry; (2): to compare studies that examined the different methods used to identify tumour budding; and (3) to examine the impact of tumour budding on survival in primary operable colorectal cancer. Results from the present review suggest that tumour budding can be considered a promising and strong prognostic factor in colorectal cancer. However, the implementation of the assessment of tumour budding in routine pathological work will depend on a selected, internationally accepted scoring system and validation against other established prognostic factors in patients with colorectal cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Prognosis; Survival; Tumour budding

Mesh:

Year:  2014        PMID: 25549950     DOI: 10.1016/j.ctrv.2014.12.007

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  31 in total

1.  Tumour budding predicts increased recurrence after curative resection for T2N0 colorectal cancer

Authors:  Richard Garfinkle; Lawrence Lee; Marylise Boutros; Marie-Josee Cardin; Alan Spatz; Nancy Morin
Journal:  Can J Surg       Date:  2019-10-01       Impact factor: 2.089

2.  Perinerural, lymphovascular and depths of invasion in extrapolating nodal metastasis in oral cancer.

Authors:  Alkananda Sahoo; Swagatika Panda; Neeta Mohanty; Debkant Jena; Niranjan Mishra; Manas R Baisakh
Journal:  Clin Oral Investig       Date:  2019-05-28       Impact factor: 3.573

3.  Lymphovascular invasion, perineural invasion, and tumor budding are prognostic factors for stage I colon cancer recurrence.

Authors:  Seijong Kim; Jung Wook Huh; Woo Yong Lee; Seong Hyeon Yun; Hee Cheol Kim; Yong Beom Cho; Yoon Ah Park; Jung Kyong Shin
Journal:  Int J Colorectal Dis       Date:  2020-02-28       Impact factor: 2.571

4.  Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.

Authors:  Han-Na Kim; Soo Yeon Lee; Baek-Hui Kim; Chung-Yeul Kim; Aeree Kim; Hayeon Kim
Journal:  Virchows Arch       Date:  2021-01-04       Impact factor: 4.064

5.  Prognostic Significance of Lacunarity in Preoperative Biopsy of Colorectal Cancer.

Authors:  Gorana Aralica; Martina Šarec Ivelj; Arijana Pačić; Josip Baković; Marija Milković Periša; Anteja Krištić; Paško Konjevoda
Journal:  Pathol Oncol Res       Date:  2020-07-02       Impact factor: 3.201

Review 6.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Authors:  Alessandro Lugli; Richard Kirsch; Yoichi Ajioka; Fred Bosman; Gieri Cathomas; Heather Dawson; Hala El Zimaity; Jean-François Fléjou; Tine Plato Hansen; Arndt Hartmann; Sanjay Kakar; Cord Langner; Iris Nagtegaal; Giacomo Puppa; Robert Riddell; Ari Ristimäki; Kieran Sheahan; Thomas Smyrk; Kenichi Sugihara; Benoît Terris; Hideki Ueno; Michael Vieth; Inti Zlobec; Phil Quirke
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

7.  Tumor Budding as a Marker for Poor Prognosis and Epithelial-Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Nishant Thakur; Muhammad Joan Ailia; Yosep Chong; Ok Ran Shin; Kwangil Yim
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

8.  Adjuvant chemotherapy in stage II and III colon cancer: the role of the "budding and TILs-(tumor-infiltrating lymphocytes) combination" as tumor-host antagonists.

Authors:  Corinna Lang-Schwarz; Balint Melcher; Theresa Dregelies; Zahra Norouzzadeh; Stefanie Rund-Küffner; Klaus Lang-Schwarz; Michael Vieth; William Sterlacci
Journal:  Int J Colorectal Dis       Date:  2021-03-20       Impact factor: 2.571

9.  Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.

Authors:  Bijiao Zhou; Shumin Zong; Weilong Zhong; Yixuan Tian; Lumeng Wang; Qian Zhang; Renya Zhang; Lei Li; Wei Wang; Jianmin Zhao; Xin Chen; Yaju Feng; Binghui Zhai; Tao Sun; Yanrong Liu
Journal:  Oncogene       Date:  2019-11-01       Impact factor: 8.756

10.  The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer.

Authors:  F J A Gujam; D C McMillan; Z M A Mohammed; J Edwards; J J Going
Journal:  Br J Cancer       Date:  2015-08-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.